{
    "clinical_study": {
        "@rank": "168012", 
        "arm_group": {
            "arm_group_label": "Study treatment", 
            "arm_group_type": "Experimental", 
            "description": "All enrolled subjects will receive one Ulthera System Treatment."
        }, 
        "brief_summary": {
            "textblock": "Enrolled subjects will receive one UltherapyTM treatment on the abdomen. Follow-up visits\n      will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment,\n      immediately post-treatment, and at each follow-up visit."
        }, 
        "brief_title": "Feasibility Study: Evaluation of the Ulthera\u00ae System for Treatment of Abdominal Tissue", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Skin Laxity", 
            "Skin Crepiness"
        ], 
        "condition_browse": {
            "mesh_term": "Cutis Laxa"
        }, 
        "detailed_description": {
            "textblock": "This is a prospective, single-center, pilot clinical trial to evaluate the efficacy of the\n      Ulthera\u00ae System for improving laxity/crepiness and texture of abdominal tissue.  Changes\n      from baseline in the laxity, crepiness and texture of abdominal skin will be assessed at\n      each study follow-up visit. Global Aesthetic Improvement Scale scores, assessments of dermal\n      thickness, and patient satisfaction questionnaires will also be obtained."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female, aged 25 to 60 years.\n\n          -  Subject in good health.\n\n          -  Skin laxity in the abdomen\n\n          -  Understands and accepts the obligation not to undergo any other procedures in the\n             areas to be treated through the follow-up period.\n\n          -  Willingness and ability to comply with protocol requirements, including returning for\n             follow-up visits and abstaining from exclusionary procedures for the duration of the\n             study.\n\n        Exclusion Criteria:\n\n          -  Presence of an active systemic or local skin disease that may affect wound healing.\n\n          -  Severe solar elastosis.\n\n          -  Excessive subcutaneous fat in the abdomen.\n\n          -  Excessive skin laxity on the abdomen.\n\n          -  Significant scarring in areas to be treated.\n\n          -  Open wounds or lesions in the area to be treated.\n\n          -  Inability to understand the protocol or to give informed consent.\n\n          -  BMI equal to and greater than 30."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01708499", 
            "org_study_id": "ULT-128"
        }, 
        "intervention": {
            "arm_group_label": "Study treatment", 
            "description": "Focused ultrasound energy delivered below the surface of the skin", 
            "intervention_name": "Ulthera System Treatment", 
            "intervention_type": "Device", 
            "other_name": "Ultherapy\u2122"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Ulthera\u00ae System", 
            "Ultherapy\u2122 Treatment", 
            "Ulthera, Inc.", 
            "Ultrasound treatment for skin tightening"
        ], 
        "lastchanged_date": "June 27, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Pasadena", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "91105"
                }, 
                "name": "Sasaki Advanced Aesthetic Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Feasibility Study: Evaluation of the Ulthera\u00ae System for Efficacious and Safe Treatment of Laxity/Crepiness and Texture of Abdominal Tissue", 
        "overall_official": {
            "last_name": "Gordon Sasaki, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Determined by a masked, qualitative assessment of photographs at 90 days post treatment compared to baseline", 
            "measure": "Improvement laxity/crepiness and texture of abdominal tissue", 
            "safety_issue": "No", 
            "time_frame": "90 days post-treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01708499"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The Global Aesthetic Improvement Scale scores will be obtained from the investigator and subject, comparing post-treatment photos to pre-treatment photos.", 
            "measure": "Overall aesthetic improvement", 
            "safety_issue": "No", 
            "time_frame": "180 days post-treatment"
        }, 
        "source": "Ulthera, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ulthera, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}